Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma

Guillermo Fernández‐Varo, Meritxell Perramón, Silvia Carvajal, Denise Oró, Eudald Casals, Loreto Boix, Laura Oller, Laura Macías‐Muñoz, Santi Marfà, Gregori Casals, Manuel Morales‐Ruiz, Pedro Casado, Pedro R. Cutillas, Jordi Bruix, Miquel Navasa, Josep Fuster, Juan Carlos Garcia‐Valdecasas, Mihai C. Pavel, Víctor Puntes, Wladimiro Jiménez – 21 January 2020

Thirty‐Day Readmission and Cost Analysis in Patients With Cirrhosis: A Nationwide Population‐Based Data

Sakkarin Chirapongsathorn, Kittiyod Poovorawan, Ngamphol Soonthornworasiri, Wirichada Pan‐ngum, Kamthorn Phaosawasdi, Sombat Treeprasertsuk – 21 January 2020 – Accurate population‐based data are needed on the rate, economic impact, and the long‐term outcomes of readmission among patients with cirrhosis.

Prognostic Factors in Pediatric Early Liver Retransplantation

Isabel Cañon Reyes, Esteban Halac, Diego Aredes, Leandro Lauferman, Guillermo Cervio, Marcelo Dip, Julia Minetto, Hayellen Reijenstein, Veronica Meza, Maria Gole, Agustina Jacobo Dillon, Oscar Imventarza – 21 January 2020 – The most common indications for early liver retransplantation (eRe‐LT) are vascular complications and primary nonfunction (PNF). These patients are usually in a critical clinical condition that can affect their chances of survival. In fact, the survival of these patients is usually lower compared with the patients undergoing a first transplant.

Hepatology Highlights

Pir A. Shah, Daryl T.Y. Lau, Nicholas W. Russo, Robert S. Brown, Jessica L. Maiers, Robert E. Schwartz, Norihiro Imai, Tibor I. Krisko, Amaia Navarro‐Corcuera, Nidhi Jalan‐Sakrikar, Joseph F. Pisa, Arun B. Jesudian, Zaid H. Tafesh, Brett E. Fortune, Enis Kostallari – 21 January 2020

Multicenter Validation of Association Between Decline in MRI‐PDFF and Histologic Response in NASH

Rohit Loomba, Brent A Neuschwander‐Tetri, Arun Sanyal, Naga Chalasani, Anna Mae Diehl, Norah Terrault, Kris Kowdley, Srinivasan Dasarathy, David Kleiner, Cynthia Behling, Joel Lavine, Mark Van Natta, Michael Middleton, James Tonascia, Claude Sirlin, for the NASH Clinical Research Network – 21 January 2020

Subscribe to